InvestorsHub Logo
Followers 467
Posts 26907
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 142

Thursday, 10/10/2013 8:18:52 AM

Thursday, October 10, 2013 8:18:52 AM

Post# of 176
7:05AM Alkermes receives Fast Track Designation for ALKS 5461 for major depressive disorder (ALKS) 30.17 : Co announced that the FDA has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD) in patients with an inadequate response to standard therapies. Fast Track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and with the potential to address an unmet medical need.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALKS News